Identifying the Microbial Metabolome: The Missing Link Between Diet and Human Health
Identifying Microbial Metabolites and the Bacteria Responsible for Their Formation
2 other identifiers
interventional
7
0 countries
N/A
Brief Summary
There is a lot of evidence to suggest that the bacteria in our gut play a major role in maintaining our health, but very little is known about the way in which this is achieved. In this study we will identify how the bacteria in out gut change the food we eat into products that may be responsible for this effect. We will also identify which bacteria are responsible for these changes. The foods we will look at are those suggested by the American Institute of Cancer Research to help prevent cancer; leafy green vegetables (cabbage, spinach), soft fruits (strawberry) cereal (oats) and plant-based protein (soya and pea). We will feed a diet rich in these foods to volunteers, monitoring the changes to the bacteria in our gut and the products produced. We will identify which products have potential to prevent cancer and also to work out how they are being produced. This work will provide new and important information that will allow us to understand more about the link between diet and health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2016
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2019
CompletedFirst Submitted
Initial submission to the registry
February 12, 2020
CompletedFirst Posted
Study publicly available on registry
May 18, 2026
CompletedMay 18, 2026
February 1, 2020
3.3 years
February 12, 2020
May 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Gut Microbial Metabolites
Wide range of beneficial and detrimental microbial metabolites in faeces, blood and urine
At Day 3
Gut Microbial Metabolites
Wide range of beneficial and detrimental microbial metabolites in faeces, blood and urine
At Day 5
Secondary Outcomes (2)
Gut Microbial Species
At Day 3
Gut Microbial Species
At Day 5
Study Arms (6)
oat
ACTIVE COMPARATORThe intervention products will be commercially available oat provided as freeze dried powders baked into a bun.
pea
ACTIVE COMPARATORThe intervention products will be commercially available pea provided as freeze dried powders baked into a bun.
soya
ACTIVE COMPARATORThe intervention products will be commercially available soya provided as freeze dried powders baked into a bun.
strawberry
ACTIVE COMPARATORThe intervention products will be commercially available strawberry provided as freeze dried powders. The product will be consumed as bread rolls, each containing 33.3 g of the intervention product. Three rolls will be consumed per day during the five day intervention period
spinach
ACTIVE COMPARATORThe intervention products will be commercially available spinach provided as freeze dried powders baked into a bun.
kale
ACTIVE COMPARATORThe intervention products will be commercially available kale provided as freeze dried powders baked into a bun.
Interventions
The intervention products will be consumed as bread rolls, each containing 33.3 g of the intervention product. Three rolls will be consumed per day during the five day intervention period, in addition to the prescribed low-phytochemical diet.
Eligibility Criteria
You may qualify if:
- healthy male or females
- aged between 18 and 55 years
- able to give informed consent.
You may not qualify if:
- are taking any medicines prescribed by their GP
- are taking drugs to lower high cholesterol levels or high blood pressure
- regularly take analgesics, antipyretic or anti-inflammatories
- regularly take nutritional supplements
- have taken antibiotics in the last three months
- have given a large blood donation in last three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aberdeenlead
- National Cancer Institute (NCI)collaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wendy R Russell, PhD
University of Aberdeen Rowett Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2020
First Posted
May 18, 2026
Study Start
May 23, 2016
Primary Completion
August 30, 2019
Study Completion
September 4, 2019
Last Updated
May 18, 2026
Record last verified: 2020-02